The efficacy, safety, and cost-effectiveness of conventional synthetic disease-modifying anti-rheumatic drugs triple therapy in preventing relapse in rheumatoid arthritis patients: a randomized controlled trial (ESCoRT study)

Juan Zhao(Peking University), Zhuoli Zhang(Peking University), Wei Zhou(Peking University), Xiaoyan Yan(Peking University), Yang Li(Peking University), Yangfeng Wu(Peking University)
Research Square
November 3, 2021
10.21203/rs.3.rs-1022084/v1
Cited by 0

Related Papers

Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy
|JAMA|2017|540
Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy
|JAMA|2022|342
Effect of Stenting Plus Medical Therapy vs Medical Therapy Alone on Risk of Stroke and Death in Patients With Symptomatic Intracranial Stenosis
|JAMA|2022|275
Factors Associated With Prehospital Delays in the Presentation of Acute Stroke in Urban China
|Stroke|2012|171
Household transitions to clean energy in a multiprovincial cohort study in China
|Nature Sustainability|2019|169